Latest Articles

Thus far, the feasibility to edit stem cells using CRISPR technology has been demonstrated in two key areas: modeling and investigating human cell states and human diseases, and regenerative medicine. In this article, we explore some of the latest research in these spaces and the approaches that scientists are adopting to overcome challenges in the field.

Just as soil testing is important to the farmer, working to improve upon current soil testing methods is important to the agricultural scientist. By ensuring that farmers and agricultural workers have access to the best possible soil testing tools, they will then be more able to protect and improve the health of their land as needed.

We report the opening night of Biodesign Here Now, an event featuring architects, artists, textile designers, and many more creatives who have found ways to bring together biology and design in their work, showing a way forward for collaboration between the two fields.

Failed drugs often are left on the shelf to gather dust. But sometimes, drugs can be dusted down and repurposed. That’s exactly the route that Katexco Pharmaceuticals has taken with its new immune system-targeting compounds, part of a new life sciences company that aims to target everything from multiple sclerosis to chronic pain.

An 8-gene assay which can non-invasively identify patients suffering from antibody-mediated rejection of kidney transplant has recently been discovered in a research study led by scientists at KU Leuven.

“An outbreak of this”, “epidemic of that”, “protect yourself against a potential pandemic of some horrible sounding disease”. In this article, we take a look at the terminology used by epidemiologists and scientists to describe the occurrence and spread of disease.

The rise of predatory conferences jeopardises the future of legitimate research events. But could conference IDs be the solution?

Epidemiological studies suggest that environmental rather than genetic factors are responsible for the current autoimmune epidemic. We take a look at how immunotolerance may be induced in affected individuals by taking inspiration from helminth infection.

The applications of CRISPR mediated genome editing are continuing to grow. The number of individuals addicted to nicotine is also continuing to grow. The solution? CRISPR-edited nicotine-free tobacco plants, say researchers Felix Stehle and Julia Schachtsiek from the Technical University of Dortmund in Germany.

For scientists investigating genomes and molecular mechanisms of microbes, it is vital that they can collate existing knowledge and understanding in the context of their current work to draw conclusions and fill gaps in knowledge. We spoke to Dr Peter Karp, leader of the BioCyc project, a microbial genomes and metabolic pathways web portal, about the evolution of BioCyc and its role in research.